2019
DOI: 10.1080/08039488.2019.1665708
|View full text |Cite
|
Sign up to set email alerts
|

Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test–retest reliability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 28 publications
1
5
0
Order By: Relevance
“…The instructions for DIEPSS users in this language version are precise to evaluate items and for interpreting the subjective distress of patients with specific items. These findings are similar to previous results on the DIEPSS as an accurate, reliable, and useful rating scale in clinical practice 3,11,12 …”
Section: Discussionsupporting
confidence: 91%
See 3 more Smart Citations
“…The instructions for DIEPSS users in this language version are precise to evaluate items and for interpreting the subjective distress of patients with specific items. These findings are similar to previous results on the DIEPSS as an accurate, reliable, and useful rating scale in clinical practice 3,11,12 …”
Section: Discussionsupporting
confidence: 91%
“…These findings are similar to previous results on the DIEPSS as an accurate, reliable, and useful rating scale in clinical practice. 3,11,12 As already suggested in the literature, ethnic differences could be a factor that alters susceptibility to adverse drug reactions, even EPS. 11,13 The assessment of drug-induced EPS is necessary among different populations to evaluate the incidence and severity of EPS in different ethnic groups.…”
Section: Discussionmentioning
confidence: 84%
See 2 more Smart Citations
“…Neurological examination revealed no upper or lower limb paralysis, bilateral elbow joint contracture in flexion due to extrapyramidal symptoms, neck retroflexion, and tardive oral dyskinesia. The drug‐induced extrapyramidal symptoms scale 5 score was 29. Hematological and biochemical test results indicated a red blood cell count of 340 × 10 4 /uL, hemoglobin level of 10.6 g/dl, blood urea nitrogen level of 10.7 mg/dl, creatinine concentration of 0.59 mg/dl, Na of 138mEq/L, K of 3.34 mEq/L, Cl of 101.0 mEq/L, Mg of 1.4 mg/dl, glycated hemoglobin of 6.9%, thyroid‐stimulating hormone level of 2.6 µU/ml, FT4 of 1.02ng/dl, troponin negativity, and a creatine kinase‐myocardial band level of 15 IU/L.…”
Section: Case Historymentioning
confidence: 99%